FDA Announces Resolution of IV Saline Solutions Shortage

Follow Drugslib on

By Stephanie Brown HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, Aug. 13, 2025 -- The nationwide shortage of sodium chloride 0.9 percent intravenous (IV) saline has officially ended, according to the U.S. Food and Drug Administration.

FDA Commissioner Marty Makary, M.D., M.P.H., stated that the shortage has ended due to the combined efforts of the FDA, Administration for Strategic Preparedness and Response, and industry partners. The teams worked together to quickly boost manufacturing and stabilize the supply chain by enabling temporary IV solution imports, expediting manufacturing reviews, and extending product expiry dates.

The sodium chloride 0.9 percent injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA is continuing efforts with manufacturers to address other IV fluid shortages and is prioritizing reliable medical product availability.

"The FDA remains focused on doing all we can to help mitigate shortages and prevent them from occurring," Makary said in a statement. "We will continue working diligently to monitor supply levels, anticipate potential disruptions, and support a robust, secure, and transparent supply chain for medical products."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-14 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords